PT  - JOURNAL ARTICLE
AU  - Perchetti, Garrett A.
AU  - Zhu, Haiying
AU  - Mills, Margaret G.
AU  - Shrestha, Lasata
AU  - Wagner, Cassia
AU  - Bakhash, Shah Mohamed
AU  - Lin, Michelle
AU  - Xie, Hong
AU  - Huang, Meei-Li
AU  - Mathias, Patrick
AU  - Bedford, Trevor
AU  - Jerome, Keith R.
AU  - Greninger, Alexander L.
AU  - Roychoudhury, Pavitra
TI  - Specific allelic discrimination of N501Y and other SARS-CoV-2 mutations by ddPCR detects B.1.1.7 lineage in Washington State
AID  - 10.1101/2021.03.10.21253321
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.03.10.21253321
4099  - http://medrxiv.org/content/early/2021/03/12/2021.03.10.21253321.short
4100  - http://medrxiv.org/content/early/2021/03/12/2021.03.10.21253321.full
AB  - Real-time epidemiological tracking of variants of interest can help limit the spread of more contagious forms of SARS-CoV-2, such as those containing the N501Y mutation. Typically, genetic sequencing is required to be able to track variants of interest in real-time. However, sequencing can take time and may not be accessible in all laboratories. Genotyping by RT-ddPCR offers an alternative to sequencing to rapidly detect variants of concern through discrimination of specific mutations such as N501Y that is associated with increased transmissibility. Here we describe the first cases of the B.1.1.7 lineage of SARS-CoV-2 detected in Washington State by using a combination of RT-PCR, RT-ddPCR, and next-generation sequencing. We screened 1,035 samples positive for SARS-CoV-2 by our CDC-based laboratory developed assay using ThermoFisher’s multiplex RT-PCR COVID-19 assay over four weeks from late December 2020 to early January 2021. S gene dropout candidates were subsequently assayed by RT-ddPCR to confirm four mutations within the S gene associated with the B.1.1.7 lineage: a deletion at amino acid (AA) 69-70 (ACATGT), deletion at AA 145, (TTA), N501Y mutation (TAT), and S982A mutation (GCA). All four targets were detected in two specimens, and follow-up sequencing revealed a total of 10 mutations in the S gene and phylogenetic clustering within the B.1.1.7 lineage. As variants of concern become increasingly prevalent, molecular diagnostic tools like RT-ddPCR can be utilized to quickly, accurately, and sensitively distinguish more contagious lineages of SARS-CoV-2.Competing Interest StatementThe authors have declared no competing interest.Funding StatementPR is a CFAR New Investigator award recipient supported by NIH AI027757.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This work was approved under a waiver of consent by the University of Washington institutional review board (STUDY00000408). All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData has been upload to GISAID, Genbank, and SRA, and code is available via Github.